Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$695M |
| 2 |
RTX Corp
RTX
|
+$549M |
| 3 |
Elevance Health
ELV
|
+$458M |
| 4 |
TransUnion
TRU
|
+$364M |
| 5 |
AbbVie
ABBV
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.08B |
| 2 |
HES
Hess
HES
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$502M |
| 4 |
Microsoft
MSFT
|
+$405M |
| 5 |
Danaher
DHR
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.44% |
| 2 | Financials | 18.84% |
| 3 | Healthcare | 13.07% |
| 4 | Industrials | 12.94% |
| 5 | Communication Services | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Energy Transfer Partners
ET
$71.2B
| $1.37M | ﹤0.01% |
+99,110
| New | +$1.35M |
|
752
Coca-Cola Consolidated
COKE
$12.5B
| $1.36M | ﹤0.01% |
14,690
+250
| +2% | +$18.1K |
|
753
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $1.33M | ﹤0.01% |
75,650
-2,392
| -3% | -$39.3K |
|
754
BioAtla
BCAB
$5.53M
| $1.3M | ﹤0.01% |
10,583
+10
| +0.1% | +$867 |
|
755
Arcturus Therapeutics
ARCT
$173M
| $1.3M | ﹤0.01% |
41,217
+3,457
| +9% | +$82.2K |
|
|
CPRX
756
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.3M | ﹤0.01% |
77,128
-2,435
| -3% | -$33.3K |
|
757
Cemex
CX
$16.3B
| $1.3M | ﹤0.01% |
167,120
+522
| +0.3% | +$3.55K |
|
758
Brighthouse Financial
BHF
$3.57B
| $1.28M | ﹤0.01% |
24,187
+388
| +2% | +$19.3K |
|
759
Centene
CNC
$31.7B
| $1.26M | ﹤0.01% |
+16,922
| New | +$1.22M |
|
760
OFG Bancorp
OFG
$2.24B
| $1.25M | ﹤0.01% |
33,455
-41,997
| -56% | -$1.38M |
|
761
Warrior Met Coal
HCC
$4.73B
| $1.21M | ﹤0.01% |
+19,810
| New | +$1.05M |
|
762
ScottsMiracle-Gro
SMG
$3.61B
| $1.17M | ﹤0.01% |
18,354
+605
| +3% | +$32.7K |
|
763
Mercado Libre
MELI
$92.8B
| $1.16M | ﹤0.01% |
740
| – | – |
|
764
Synchrony
SYF
$25.6B
| $1.13M | ﹤0.01% |
29,688
+4,877
| +20% | +$154K |
|
765
Lloyds Banking Group
LYG
$90B
| $1.13M | ﹤0.01% |
473,636
+37,556
| +9% | +$80.4K |
|
766
Ironwood Pharmaceuticals
IRWD
$701M
| $1.13M | ﹤0.01% |
+98,677
| New | +$976K |
|
767
EPR Properties
EPR
$4.7B
| $1.1M | ﹤0.01% |
22,705
+364
| +2% | +$16.2K |
|
768
Seaboard Corp
SEB
$4.1B
| $1.09M | ﹤0.01% |
+305
| New | +$1.08M |
|
769
Arcus Biosciences
RCUS
$3.61B
| $1.08M | ﹤0.01% |
56,346
-1,780
| -3% | -$28.4K |
|
770
Organogenesis Holdings
ORGO
$310M
| $1.07M | ﹤0.01% |
261,262
-8,252
| -3% | -$23.1K |
|
|
GOLD
771
Gold.com Inc
GOLD
$1.22B
| $1.07M | ﹤0.01% |
35,253
-1,113
| -3% | -$31.7K |
|
772
Bath & Body Works
BBWI
$4.06B
| $1.05M | ﹤0.01% |
24,340
| – | – |
|
773
MGM Resorts International
MGM
$11.2B
| $1.04M | ﹤0.01% |
23,290
-57,034
| -71% | -$2.24M |
|
774
CrowdStrike
CRWD
$211B
| $960K | ﹤0.01% |
15,036
+240
| +2% | +$12.6K |
|
775
Alibaba
BABA
$304B
| $959K | ﹤0.01% |
12,368
-8,004
| -39% | -$638K |
|
Similar funds
Massachusetts Financial Services's Q4 2023 Portfolio in Review
As of Q4 2023, Massachusetts Financial Services held 885 positions worth $310B, up 8.4% from $286B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q4 2023 filing shows 49 new, 322 increased, 455 reduced and 51 closed positions. Its largest new stake was Elevance Health: 990,628 shares worth $467M. The largest sale was Thermo Fisher Scientific, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q4 2023 buy was Elevance Health: 990,628 shares worth $467M.
- Massachusetts Financial Services added most to Chevron in Q4 2023, an estimated $695M increase.
- Massachusetts Financial Services's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $1.08B.
- Massachusetts Financial Services fully exited Caterpillar in Q4 2023, selling an estimated $146M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $310B portfolio in Q4 2023.
- Massachusetts Financial Services opened 49 new positions and closed 51 in Q4 2023.
- Massachusetts Financial Services's portfolio value rose 8.4% quarter-over-quarter to $310B.
Based on Massachusetts Financial Services's 13F filing for Q4 2023, filed 8 Feb 2024.